Walkersville, USA / Cologne, Germany, 20 February 2013 – There are many Limulus Amebocyte Lysate (LAL) methods commercially available today. Hence, Lonza is hosting a free, 60-minute webinar entitled "Endotoxin Detection – Which Method Is Best for Me" at two different dates and times. The sessions address assay performances and limitations for quality control (QC) professionals and will be followed by a live Q&A. The first webinar is scheduled for 19 March 2013 at 10 AM CET (Berlin). The second session will be held on 20 March 2013 at 2 PM EST (New York). For more details, please visitwww.lonza.com/webinar1.
The webinar will cover endotoxin detection practices to test products for the presence of Gram-negative bacteria. These methods include gel clot, semi-quantitative gel clot, chromogenic endpoint, turbidimetric endpoint, kinetic chromogenic and kinetic turbidimetric. The presenters will share a look at the advantages and disadvantages of each assay. More specifically, attendees will learn which assay is more appropriate for their individual testing needs and how each assay is performed. In addition, the presenters will give details on alternatives to the traditional LAL-based assay. Endotoxin detection tests are performed on raw and in-process materials and for the final release of products in the pharmaceutical and medical device industries. All those interested being unable to join the webinar, please visit Lonza’s Endotoxin Detection page www.lonza.com/lal for more information.
QC professionals are invited to attend the free webinar by registering for their preferred date:
- Tuesday, 19 March 2013 – 9 AM GMT (London) / 10 AM CET (Berlin) / 6 PM JST (Tokyo)Speaker: Saskia Ihle, Scientific Support Specialist at Lonza Cologne GmbH
19 March 2013 Register Here
- Wednesday, 20 March 2013 – 2 PM EST (New York) / 11 AM PST (Los Angeles) Speaker: Travis Wallace, Scientific Support Specialist at Lonza Walkersville Inc
20 March 2013 Register Here
The upcoming June webinar will be focusing on rapid mycoplasma detection presenting the Roche MycoTOOL® Test, available through Lonza.
Download PDF Version of Product News
About Lonza Pharma – Bioscience Solutions
Lonza provides the pharma market with the tools life science researchers use to develop and test therapeutics, from basic research through to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software to ensure product quality. Lonza Pharma – Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions. The company delivers physiologically relevant cell biology solutions, biomarker discovery services, technologies to understand compound action and complete solutions for rapid microbiology. Primary brands include BioWhittaker™, Clonetics™, FlashGel™, MetaPhor™, MycoAlert™, Nucleofection™, NuSieve™, PAGEr™, Poietics™ and SeaKem®.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). In 2012, the company had sales of CHF 3.925 billion. Further information can be found at www.lonza.com.
Further Information
Lonza Cologne GmbH
Marketing Communications and Product PR
Corinna König-Wildförster
Phone +49 221 99199 464
pr.cologne@lonza.com
Lonza Group Ltd
Media Relations
Melanie Disa
Phone +1 201 316 9413
Fax +1 201 696 3533
melanie.disa@lonza.com